Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd love to, but I'm already tapped out.
Man, the shorting is relentless. Low volume sledgehammer “selling”.
Legitimately one of the most manipulated stocks I’ve ever been associated with.
It’s criminal that anyone would be selling below $10 at this point.
Get it!
A substantial increase!
Very interesting. Seems like it was buried a bit.
Reread what he posted.
Sure. But it will by the end of Feb.
Yep
It's amazing how much we have to beg people to come get rich in a couple months or so.
There will probably be a shell resurgence for a while, until enough new investors get burnt again.
Very cyclical, but it looks like Moody plays are worth a few bucks up front.
Excellent pace!!!!
Long term? I firmly believe $100+.
We'll see if the market agrees.
I’ve looked at over and over again, and I don’t see any single stock with this much upside potential outside of a freak penny stock or something like a sudden GME short squeeze.
$100 would only be a 5 billion market cap for a biotech with a SOLID upcoming pipeline? It’s ridiculous.
It's important to note that this is a fringe hypothetical. Management might not believe a buyout is even a good idea. It's quite possible the share price will eventually support a 5-10 billion market cap on its own.
I have two very small accounts that I'll be using as my 2 year HGEN plan. My main account might still sell 1/3 at $30 to protect my downside, but I'm starting to think much longer term on HGEN as an investment that will be worthy of long-term capital gains and the potential opportunity cost of other plays.
My original thought was to play for $30 a share (ballpark) and just get out after the trial extension and EUA delay. However, MWM's post highlights that a GILD buyout isn't far-fetched.
Is it likely? There's no evidence to support going that far, but GILD doesn't have anything for COVID or for treating cytokine storm in general. They've partnered in the past, and a market cap of 5 billion would still represent a significant opportunity to acquire a promising pipeline down the road. That's around $100 a share, which is why so many of us consider the current price to be highway robbery.
Holding as late as early summer might be enough time to find out if GILD is interested assuming the P3 data is as good as we all expect it to be. I expect the share price to have risen significantly at that point, allowing a safe partial exit with plenty of remaining upside.
Awesome!
HGEN better hit in Jan, or this might have been one of my most wasted opportunities ever. GME killing it!
Happy Thanksgiving!
I can't be the only one here who believes that once the data is released, manufacturing is going to skyrocket as additional funding pours in.
From a tax perspective, it wouldn't hurt my feelings for it to boom in January.
I'd rather have a whole year and a half to deal with the upcoming taxes rather than have them hit in a few months.
That's a lot more time with extra capital to generate cash flow before paying Uncle Sam.
And yet it also feels low.
I’d consider selling above 30, but damn it has $100+ potential.
$30 is what, 1.5 billion cap? Chump change for a drug whose first 100k doses are expected to yield a billion dollars.
Christ, apply for a EUA in December, please!
We must be close to 75% and an interim review!
Let's GO!
Feels like a crash coming quickly. So many stocks are parabolic at the same time.
Page 11.
The header is a copy/paste error. Not uncommon with them for unaudited filings.
According to their financials, yes. They sold some off, but retained quite a bit. Stock Barber is a great JNSH resource. Check his posts
If you need any info on JNSH, I was invested for years.
It’s interesting for sure.
Just read it; thanks for posting here.
Ok, right through it really quick.
Basically he took the same monoclonal antibody that Trump previously took.
No drug or company identified.
Fair enough, lol!
Mind just giving everyone a quick recap?
Hey, no way you’ve lost more than me this year as a percentage, lol!
Oil by night, Solar by day.
Duh. Obvious.
December and January. I’m betting the farm on a massive move.
Says he took an herbal extract and got better.
Sure sure. No idea what it has to do with HGEN.
https://www.google.com/amp/s/www.forbes.com/sites/elanagross/2020/11/19/ben-carson-says-he-took-oleandrin-an-fda-rejected-supplement-touted-by-mypillow-founder-as-coronavirus-treatment/amp/
I'm not disagreeing. Also, there's always a chance things are accelerated.
But after the trial was increased to more than 500 from the original 300, the entire timeline shifted to the right.
We have to trust that Management is doing what they're claiming: they're in daily contact with Operation Warp Speed.
They’ve stated they’re applying in Q1 2021, very likely January (on track).
Things might accelerate before then, but that’s the plan.
Could it just fucking wait until HGEN blows up in January?!
I'd really like to take big profits from there and sink it all here before this goes to $50.
Christ, be considerate of my portfolio, k thx.